Importantly, our MMTV-HER2/MMTV-MED1 mouse model reported here will not only allow for better understanding of the molecular mechanisms of HER2/MED1 in tumorigenesis but also offer a more clinically relevant tumor model where both HER2 and MED1 are overexpressed for preclinical trials. The gene discussed is ERBB2; the disease is neoplasm.